Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
RaySearch Laboratories AB ( ($SE:RAY.B) ) has shared an update.
RaySearch Laboratories’ long-time partner Iridium Network in Belgium has delivered the first online adaptive radiation treatment using RaySearch’s RayStation and RayCare systems on a widely deployed Varian TrueBeam linear accelerator. The milestone treatment, completed on May 11, 2026, showcases how RaySearch’s integrated software can retrofit common radiotherapy machines with advanced adaptive capabilities, potentially broadening access to precision cancer care and strengthening the company’s competitive position against rivals that rely on specialized hardware.
By enabling radiotherapy plans to be re-optimized in real time based on daily patient imaging, the RayStation–RayCare combination supports highly precise targeting of tumors while reducing damage to healthy tissue and streamlining clinical workflows. This demonstration at Iridium underscores the strategic value of RaySearch’s workflow automation, deep learning segmentation, and direct machine interfacing, and it may help drive greater adoption of RayCare and RayStation across existing TrueBeam-installed bases worldwide.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a Sweden-based medical technology company specializing in software for advanced cancer treatment. Its portfolio includes the RayStation treatment planning system, the RayCare oncology information system, and complementary platforms RayIntelligence and RayCommand, which are used by more than 1,200 clinics in 51 countries and target the global radiotherapy and oncology IT market.
Average Trading Volume: 176,219
Technical Sentiment Signal: Hold
Current Market Cap: SEK6.27B
See more data about RAY.B stock on TipRanks’ Stock Analysis page.